NCRI calls for greater lung cancer funding
The National Cancer Research Institute (NCRI) has called for greater research into lung cancer in a report released at its annual conference in Birmingham.
Lung cancer is the most common cancer in the world and accounts for 22 per cent of all cancer deaths in Britain, but only attracts 3.9 per cent of research funding.
The report identifies some of the reasons why lung cancer receives less attention than other cancers and lays out strategies to tackle these problems to ensure adequate funding.
The principal barrier to research appeared to be the widespread perception in the scientific community that lung cancer is a highly complex field and difficult to treat successfully, said the NRCI.
"We welcome today's report from the NCRI because it sets out positive actions to further increase lung cancer research in the UK," said Professor Alex Markham of Cancer Research UK.
"Cancer Research UK is the largest funder of lung cancer research in Britain.
"The charity's recent achievements include a huge increase in the number of clinical trials we fund into lung cancer, including a large trial of Tarceva and other trials looking at selective screening for high-risk groups and the best way to combine radiotherapy and chemotherapy to treat the disease.
"Nine out of ten cases of lung cancer are related to smoking tobacco. We continue to fund research into tobacco control, how to enable people to quit, and new ways to treat lung cancer.
"Together with its partners and supporters, Cancer Research UK's vision is to beat all types of cancer.
"We hope to see the actions proposed by the NCRI fully implemented, maintaining the increase in the number and quality of proposals we are receiving for research into lung cancer."